People | April 29, 2026
NADMED Limited appoints James Lee as CEO to drive global expansion
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
The Union Minister noted that heat stress contributes to a rise in both communicable diseases such as dengue and non-communicable conditions like cardiovascular disorder
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Subscribe To Our Newsletter & Stay Updated
